Published Mar 11, 2024

Moderna's CFO on How to Allocate Capital in Big Pharma

Jamey Mock, CFO of Moderna, delves into the complexities of capital allocation in the pharmaceutical industry, detailing Moderna's strategic financial management, investment plans, and the impact of government partnerships like Operation Warp Speed on accelerating medical innovations.

Episode Highlights

Topics covered

Biotech Industry Dynamics
01
CFO Responsibilities
02
Strategic Resource Allocation
03
Government Partnerships
04

Moderna's CFO on How to Allocate Capital in Big Pharma

Topics covered

Popular Clips

Navigating Technological Enthusiasm

Internal Product Allocation

Moderna's mRNA Revolution

Pharma vs. Aviation

Moderna's Pandemic Rise

Strategic Product Governance

Market Signals

CFO Insights

Green Future Collaboration

Strategic Decision Making

Company Interest Rates

Long-Term Investor Strategy

Accelerating Medical Breakthroughs

Biotech Funding Strategies

Episode Highlights

Biotech Industry Dynamics

CFO Responsibilities

Strategic Resource Allocation

Government Partnerships

Moderna's CFO on How to Allocate Capital in Big Pharma

Topics covered

Popular Clips

Episode Highlights

Biotech Industry Dynamics

CFO ResponsibilitiesJamey Mock, Moderna's CFO, discusses the intricacies of capital allocation and investor relations in the pharmaceutical industry. He highlights the importance of strategic financial management and clear communication with investors to ensure the company's growth and stability.

CFO Responsibilities

Strategic Resource Allocation

Government PartnershipsJamey Mock discusses the transformative impact of Operation Warp Speed on vaccine development and regulatory processes. He emphasizes the role of government partnerships in accelerating medical breakthroughs and de-risking investments for pharmaceutical companies.

Government Partnerships